McLaughlin Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.81M Sell
4,147
-244
-6% -$247K 3.65% 3
2025
Q4
$4.72M Buy
+4,391
New +$4.2M 4.22% 3

Other funds holding LLY

McLaughlin Asset Management's LLY Position: Q1 2026 in Review

McLaughlin Asset Management reduced its Eli Lilly (LLY) stake by 5.6% in Q1 2026, selling an estimated $247K and leaving 4,147 shares worth $3.81M. The position accounts for 3.65% of the portfolio, ranked #3.

McLaughlin Asset Management first reported a position in LLY in Q4 2025 and has held it in 2 quarters since. The position peaked at $4.72M in Q4 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • McLaughlin Asset Management held 4,147 shares of Eli Lilly worth $3.81M as of Q1 2026.
  • McLaughlin Asset Management sold 244 Eli Lilly shares in Q1 2026, an estimated $247K.
  • Eli Lilly made up 3.65% of McLaughlin Asset Management's portfolio in Q1 2026, its #3 holding.
  • McLaughlin Asset Management first reported a position in Eli Lilly in Q4 2025 and has held it in 2 quarters since.
  • McLaughlin Asset Management's Eli Lilly position peaked at $4.72M in Q4 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on McLaughlin Asset Management's 13F filing for Q1 2026, filed 29 Apr 2026.